A novel RNA binding protein-associated prognostic model to predict overall survival in hepatocellular carcinoma patients. Issue 29 (23rd July 2021)

• Record Type: Journal Article
• Authors: Liu, Ye; Liu, Xiaohong; Gu, Yang; Lu, Haofeng
• Other Names: Pocha. Christine section editor.
• Is Part Of: Medicine. Volume 100:Issue 29(2021)
• Publication Date: 2021-07-23
• Subjects: hepatocellular carcinoma -- overall survival -- prognostic model -- RNA binding proteins; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000026491
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract : Abstract: Hepatocellular carcinoma (HCC) is 1 of the deadliest malignancies worldwide. Despite significant advances in diagnosis and treatment, the mortality rate from HCC persists at a substantial level. Construction of a prognostic model that can reliably predict HCC patients' overall survival is urgently needed. Two RNA-seq dataset (the Cancer Genome Atlas and International Cancer Genome Consortium) and 1 microarray dataset (GSE14520) were included in our study. RNA-binding proteins (RBPs) in HCC patients was examined by differentially expressed genes analysis, functional enrichment analysis and protein-protein interaction network analysis. Subsequently, the Cancer Genome Atlas dataset was randomly divided into training and testing cohort with a prognostic model developed in the training cohort. In order to evaluate the prognostic value of the model, a comprehensive survival assessment was conducted. Five RBPs (ribosomal protein L10-like, enhancer of zeste homolog 2 (EZH2), peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A), zinc finger protein 239, interferon-induced protein with tetratricopeptide repeats 1) were used to construct the model. The model accurately predicted the prognosis of liver cancer patients in both the training cohort and validation cohort. HCC patients could be assigned into a high-risk group and a low-risk group by this model, and the overall survival of these 2 groups was significantly different ( P < .05). Furthermore, the risk scores obtained by this model were highly correlated with immune cell infiltration. The prognostic model helps to identify HCC patients at high risk of mortality, which optimizes decision-making for individualized treatment.